• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体羰基与疏水侧链之间的结合协同性可通过额外的氢键以距离依赖的方式增强:凝血酶抑制剂的案例研究。

Binding cooperativity between a ligand carbonyl group and a hydrophobic side chain can be enhanced by additional H-bonds in a distance dependent manner: A case study with thrombin inhibitors.

作者信息

Said Ahmed M, Hangauer David G

机构信息

Department of Chemistry, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA.

出版信息

Eur J Med Chem. 2015;96:405-24. doi: 10.1016/j.ejmech.2015.03.059. Epub 2015 Mar 27.

DOI:10.1016/j.ejmech.2015.03.059
PMID:25912673
Abstract

One of the underappreciated non-covalent binding factors, which can significantly affect ligand-protein binding affinity, is the cooperativity between ligand functional groups. Using four different series of thrombin inhibitors, we reveal a strong positive cooperativity between an H-bond accepting carbonyl functionality and the adjacent P3 hydrophobic side chain. Adding an H-bond donating amine adjacent to the P3 hydrophobic side chain further increases this positive cooperativity thereby improving the Ki by as much as 546-fold. In contrast, adding an amidine multiple H-bond/salt bridge group in the distal S1 pocket does not affect this cooperativity. An analysis of the crystallographic B-factors of the ligand groups inside the binding site indicates that the strong cooperativity is mainly due to a significant mutual reduction in the residual mobility of the hydrophobic side chain and the H-bonding functionalities that is absent when the separation distance is large. This type of cooperativity is important to encode in binding affinity prediction software, and to consider in SAR studies.

摘要

一种未得到充分重视的非共价结合因素,它可显著影响配体与蛋白质的结合亲和力,即配体官能团之间的协同作用。我们使用四种不同系列的凝血酶抑制剂,揭示了一个氢键接受羰基官能团与相邻的P3疏水侧链之间存在很强的正协同作用。在P3疏水侧链附近添加一个氢键供体胺会进一步增强这种正协同作用,从而使抑制常数(Ki)提高多达546倍。相比之下,在远端S1口袋中添加一个脒基多氢键/盐桥基团并不会影响这种协同作用。对结合位点内配体基团的晶体学B因子分析表明,这种强协同作用主要是由于疏水侧链与氢键官能团的残余流动性显著相互降低,而当分离距离较大时则不存在这种情况。这种协同作用类型对于在结合亲和力预测软件中进行编码以及在构效关系(SAR)研究中加以考虑非常重要。

相似文献

1
Binding cooperativity between a ligand carbonyl group and a hydrophobic side chain can be enhanced by additional H-bonds in a distance dependent manner: A case study with thrombin inhibitors.配体羰基与疏水侧链之间的结合协同性可通过额外的氢键以距离依赖的方式增强:凝血酶抑制剂的案例研究。
Eur J Med Chem. 2015;96:405-24. doi: 10.1016/j.ejmech.2015.03.059. Epub 2015 Mar 27.
2
Ligand binding cooperativity: Bioisosteric replacement of CO with SO2 among thrombin inhibitors.配体结合协同性:凝血酶抑制剂中用二氧化硫对一氧化碳进行生物电子等排体置换
Bioorg Med Chem Lett. 2016 Aug 15;26(16):3850-4. doi: 10.1016/j.bmcl.2016.07.024. Epub 2016 Jul 9.
3
Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors.协同作用增强疏水相互作用和氢键强度:凝血酶抑制剂同系列的合成、建模和分子动力学模拟。
J Med Chem. 2010 Mar 11;53(5):2126-35. doi: 10.1021/jm9016416.
4
How a β-D-glucoside side chain enhances binding affinity to thrombin of inhibitors bearing 2-chlorothiophene as P1 moiety: crystallography, fragment deconstruction study, and evaluation of antithrombotic properties.β-D-葡萄糖苷侧链如何增强含 2-氯噻吩作为 P1 部分的抑制剂与凝血酶的结合亲和力:晶体学、片段解构研究和抗血栓形成特性评价。
J Med Chem. 2014 Oct 23;57(20):8563-75. doi: 10.1021/jm5010754. Epub 2014 Oct 14.
5
Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.采用基于配体和基于结构的联合方法,剖析代表性因子 Xa 和凝血酶抑制剂的选择性结构决定因素。
J Chem Inf Model. 2011 Aug 22;51(8):1966-85. doi: 10.1021/ci200185q. Epub 2011 Aug 1.
6
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.精制的2.3A 牛凝血酶与基于苯甲脒和精氨酸的凝血酶抑制剂NAPAP、4-TAPAP和MQPA形成的X射线晶体结构。改进抗血栓药物的起点。
J Mol Biol. 1992 Aug 20;226(4):1085-99. doi: 10.1016/0022-2836(92)91054-s.
7
Identification of structural-kinetic and structural-thermodynamic relationships for thrombin inhibitors.鉴定凝血酶抑制剂的结构-动力学和结构-热力学关系。
Biochemistry. 2013 Jan 29;52(4):613-26. doi: 10.1021/bi301333z. Epub 2013 Jan 16.
8
Modulating hydrogen-bond basicity within the context of protein-ligand binding: A case study with thrombin inhibitors that reveals a dominating role for desolvation.在蛋白质-配体结合背景下调节氢键碱性:以凝血酶抑制剂为例的研究揭示了去溶剂化的主导作用。
Eur J Med Chem. 2017 Jan 5;125:975-991. doi: 10.1016/j.ejmech.2016.09.038. Epub 2016 Sep 13.
9
Non-additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry.功能基团贡献在蛋白质-配体结合中不具有加和性:晶体学和等温热滴定法的综合研究。
J Mol Biol. 2010 Apr 9;397(4):1042-54. doi: 10.1016/j.jmb.2010.02.007. Epub 2010 Feb 12.
10
Additivity or cooperativity: which model can predict the influence of simultaneous incorporation of two or more functionalities in a ligand molecule?加性或协同性:哪种模型可以预测同时将两种或多种功能并入配体分子中的影响?
Eur J Med Chem. 2015 Jan 27;90:897-915. doi: 10.1016/j.ejmech.2014.11.056. Epub 2014 Nov 28.

引用本文的文献

1
Inhibitor design for TMPRSS2: insights from computational analysis of its backbone hydrogen bonds using a simple descriptor.基于简单描述符的 TMPRSS2 骨干氢键计算分析对抑制剂设计的启示
Eur Biophys J. 2024 Feb;53(1-2):27-46. doi: 10.1007/s00249-023-01695-4. Epub 2023 Dec 29.
2
Design, synthesis, and evaluation of a novel benzamidine-based inhibitor of VEGF-C binding to Neuropilin-2.设计、合成及评价一种新型苯甲脒类抑制剂,其可与 Neuropilin-2 结合抑制 VEGF-C。
Bioorg Chem. 2020 Jul;100:103856. doi: 10.1016/j.bioorg.2020.103856. Epub 2020 Apr 16.
3
Theoretical investigation into the cooperativity effect between the intermolecular π∙π and H-bonding interactions in the curcumin∙cytosine∙HO system.
姜黄素∙胞嘧啶∙HO体系中分子间π∙∙π和氢键相互作用协同效应的理论研究
J Mol Model. 2018 Sep 28;24(10):298. doi: 10.1007/s00894-018-3836-z.
4
Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases.用于治疗血栓性疾病的口服活性凝血酶抑制剂的研发
Molecules. 2015 Jun 15;20(6):11046-62. doi: 10.3390/molecules200611046.